Bioservo outsources all production to partner companies and implements cost savings
The next generation Carbonhand® is now, after completed safety tests, approved as a medical device according to the MDR, and sales are starting in several European countries. Through the approval, Bioservo has two stable product platforms to commercialize, previously Ironhand® in industry and now also Carbonhand® for patients with impaired hand function. In the new phase the company is now entering, all production of the company's products will be handled by external partners. This allows Bioservo to streamline the organization to focus on developing and maintaining effective partner